1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Discovery and characterization of an endogenous CXCR4 antagonist.

      1 , 1 , 2 , 1 , 1 , 1 , 1 , 3 , 3 , 4 , 5 , 5 , 6 , 6 , 7 , 7 , 8 , 9 , 10 , 10 , 11 , 12 , 12 , 11 , 13 , 14 , 14 , 14 , 15 , 16 , 17 , 12 , 18 , 3 , 19 , 20
      Cell reports

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CXCL12-CXCR4 signaling controls multiple physiological processes and its dysregulation is associated with cancers and inflammatory diseases. To discover as-yet-unknown endogenous ligands of CXCR4, we screened a blood-derived peptide library for inhibitors of CXCR4-tropic HIV-1 strains. This approach identified a 16 amino acid fragment of serum albumin as an effective and highly specific CXCR4 antagonist. The endogenous peptide, termed EPI-X4, is evolutionarily conserved and generated from the highly abundant albumin precursor by pH-regulated proteases. EPI-X4 forms an unusual lasso-like structure and antagonizes CXCL12-induced tumor cell migration, mobilizes stem cells, and suppresses inflammatory responses in mice. Furthermore, the peptide is abundant in the urine of patients with inflammatory kidney diseases and may serve as a biomarker. Our results identify EPI-X4 as a key regulator of CXCR4 signaling and introduce proteolysis of an abundant precursor protein as an alternative concept for chemokine receptor regulation.

          Related collections

          Author and article information

          Journal
          Cell Rep
          Cell reports
          2211-1247
          May 5 2015
          : 11
          : 5
          Affiliations
          [1 ] Institute of Molecular Virology, University of Ulm, 89081 Ulm, Germany.
          [2 ] Institute of Molecular Virology, University of Ulm, 89081 Ulm, Germany; Ulm Peptide Pharmaceuticals, University of Ulm, 89081 Ulm, Germany; PHARIS Biotec GmbH, 30625 Hannover, Germany.
          [3 ] German Red Cross Blood Service Baden-Württemberg-Hessen and Institute for Transfusion Medicine and Immunohaematology, Goethe University, 60528 Frankfurt, Germany.
          [4 ] German Red Cross Blood Service Baden-Württemberg-Hessen and Institute for Transfusion Medicine and Immunohaematology, Goethe University, 60528 Frankfurt, Germany; Department of Internal Medicine, Clinic of Immunology, Hannover Medical School, 30625 Hannover, Germany.
          [5 ] Institute of Pharmacology and Toxicology, University of Ulm, 89081 Ulm, Germany.
          [6 ] Department of Dermatology and Allergic Diseases, University of Ulm, 89081 Ulm, Germany.
          [7 ] Institute of Organic Chemistry III, University of Ulm, 89081 Ulm, Germany.
          [8 ] Department of Neurosurgery, University of Ulm, 89081 Ulm, Germany.
          [9 ] PHARIS Biotec GmbH, 30625 Hannover, Germany.
          [10 ] UMR7200, Therapeutic Innovation Lab, CNRS-University of Strasbourg, Faculty of Pharmacy, and LabEx Medalis, 67401 Illkirch, France.
          [11 ] UMR7242, Biotechnology and Cellular Signaling, School of Biotechnology of Strasbourg, 67412 Illkirch, France.
          [12 ] Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal-Potsdam, Germany.
          [13 ] Department of Chemistry, University San Pablo-CEU, 280040 Madrid, Spain.
          [14 ] Department of Physico-Chemical Biology, Centro de Investigaciones Biológicas, 28040 Madrid, Spain.
          [15 ] Experimental Anesthesiology Section, University Hospital Ulm, 89081 Ulm, Germany.
          [16 ] Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
          [17 ] J. Craig Venter Institute, La Jolla, CA 92037, USA.
          [18 ] Institute of Molecular Virology, University of Ulm, 89081 Ulm, Germany; PHARIS Biotec GmbH, 30625 Hannover, Germany; Department of Internal Medicine, Clinic of Immunology, Hannover Medical School, 30625 Hannover, Germany.
          [19 ] Institute of Molecular Virology, University of Ulm, 89081 Ulm, Germany; Ulm Peptide Pharmaceuticals, University of Ulm, 89081 Ulm, Germany.
          [20 ] Institute of Molecular Virology, University of Ulm, 89081 Ulm, Germany; Ulm Peptide Pharmaceuticals, University of Ulm, 89081 Ulm, Germany. Electronic address: jan.muench@uni-ulm.de.
          Article
          S2211-1247(15)00352-6
          10.1016/j.celrep.2015.03.061
          25921529
          9b17bf06-a49e-4f40-86ed-33347901313f
          Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content269

          Cited by40